Trisubstituted piperidines as renin inhibitors

Details for Australian Patent Application No. 2008334555 (hide)

Owner Novartis AG

Inventors Mah, Robert; Behnke, Dirk; Stutz, Stefan; Jotterand, Nathalie; Jelakovic, Stjepan; Herold, Peter; Tschinke, Vincenzo

Agent Davies Collison Cave

Pub. Number AU-A-2008334555

PCT Pub. Number WO2009/074674

Priority 07150019.3 13.12.07 EP

Filing date 12 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

C07D 491/107 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/113 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/074674 Priority application(s): WO2009/074674

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008334556-Fluorescent, heterocyclic annellated perylene

2008334547-Organic compounds